|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Dec―22 |
The Association Between Laboratory Biomarkers and Clinical Features in COVID-19 Pneumonia: A Potential Tool for Predicting Disease Prognosis and Severity |
Hossein Jalali, Ahmad Najafi, Lotfollah Davoodi, Abbas Alipour, Mohammad Reza Mahdavi |
2 |
[GO] |
2024―Dec―22 |
Clinical and Laboratory Characteristics of Hospitalized Patients With COVID-19 After Vaccination in Quchan-Iran |
Vahid Hajali, Bahareh Payvar, Alireza Fattahi, Kosar al-Zahra Izad Panah, Hanieh Esfahani, Ehsan Saburi, Zahra Fard Tadaion |
3 |
[GO] |
2024―Apr―24 |
Association of Lipid Profile and Inflammatory Markers With COVID-19 Severity and Outcome |
Amirhossein Khoshgoeian, Adele Bahar, Zahra Kashi, Mina Khasayesi, Shima Yahoo Torghabe, Mahmood Moosazadeh, Zahra Hosseini-khah |
4 |
[GO] |
2023―Oct―17 |
In Silico Design of a Multivalent Epitope Vaccine Against SARS-CoV-2 for Iranian Populations |
Faezeh Soltanveis, Mokhtar Nosrati |
5 |
[GO] |
2023―Oct―17 |
A Review on Suggested Mechanisms in Thrombocytopenia and Thrombosis Following ChAdOx1 nCoV-19 Vaccination |
Negar Mottaghi Dastgerdi, Homa Faghihi |
6 |
[GO] |
2022―Feb―21 |
Designing a New Multiepitope-based Vaccine Against COVID-19 |
Afshin Samimi Nemati, Majid Tafrihi, Fatemeh Sheikhi, Abolfazl Rostamian Tabari, Amirhossein Haditabar |
7 |
[GO] |
2021―Feb―13 |
Inhibitors of Angiotensin-converting Enzyme or Blockers of Angiotensin-2 Receptor in COVID-19 Patients with Comorbid Cardiovascular or Pulmonary Diseases |
Farid Rahimi, Amin Talebi Bezmin Abadi |
8 |
[GO] |
2021―Feb―09 |
What Are the Consequences When the New Year Eve in Iran Coincides With COVID-19? |
Gholamreza Farnoosh, Kazem Hassanpour, Taleb Badri, Seyed Reza Hosseini Zijoud |